JUVÉDERM ® Collection of Fillers Continues Position as the World’s Number One Chosen Dermal Filler Collection

IRVINE, Calif. , Sept. 7, 2022 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (  NYSE:   ABBV ), announced its manufacturing facility in France has reached the milestone of producing and shipping 100 million syringes associated with JUVÉDERM ® products globally. 1 Since its launch in 2000, the JUVÉDERM ® Variety of Fillers has grown to where its products are now available in more than 110 territories worldwide and it remains the particular world’s number one chosen dermal filler collection. 2, 3 This remarkable achievement is a milestone years in the making, and further demonstrates the JUVÉDERM ® Collection of Fillers’ dedication to patients and providers globally.

“This is more than just a number. 100 million JUVÉDERM ® syringes is a great source of pride for everyone at Allergan Aesthetics who helped make this happen, ” said Carrie Strom , President, Global Allergan Appearance and Senior Vice President, AbbVie. “It represents the particular millions associated with patients who’ve benefitted from our innovation and robust product offerings. We couldn’t have done this without the years of support through all our healthcare professionals who continue to believe within and trust our items. We look forward to forging ahead as a brand, setting new goals, plus continuing our own legacy as the international category leader. ”

The global success of JUVÉDERM ® is in large part due in order to its wide range of minimally invasive treatment options specifically designed with regard to different areas of the face. The JUVÉDERM ® Assortment of Injectables offers products that provide results that are long-lasting and natural-looking for popular treatment areas, including the lips, cheeks, and chin. 4-10   The JUVÉDERM ® Number of Fillers’ VYCROSS ® technology is the number one chosen dermal filler technology worldwide. The safety and efficacy of the JUVÉDERM ® Selection of Fillers  has been demonstrated in more than 330 clinical studies. 11

“I am thrilled to celebrate this momentous occasion alongside the JUVÉDERM ® Collection associated with Fillers. I trust the particular brand within my practice and have successfully offered it regarding more compared to 15 many years, ” said Dr. David Shafer , board certified plastic surgeon. “Sixteen yrs of medical studies plus safety data, the widest range of filler choices, and their rigorous testing protocols to ensure patient safety are just some associated with the reasons why I offer JUVÉDERM ® items to my patients. We look forward to the continued development from the JUVÉDERM ® Collection of Fillers and the rest of the particular Allergan Looks portfolio intended for many years to come. inch

In the U. S., the JUVÉDERM ® Collection of Injectables boasts the top chosen fillers for cheeks (JUVÉDERM ® VOLUMA ® XC), lower face wrinkles and folds (JUVÉDERM ® Ultra Plus XC and JUVÉDERM ® VOLLURE ® XC), lips (JUVÉDERM ® Ultra XC and JUVÉDERM ® VOLBELLA ® XC), and perioral lines (JUVÉDERM ® VOLBELLA ® XC), 2 all top areas of concern among patients and all places Allergan Appearances offers strong training to get. The company is dedicated to training aesthetic specialists on the use associated with all the products plus their approved indications.

“I’ve had the particular honor of serving as an Allergan Medical Institute (AMI) trainer for more than six years. The training Allergan Good looks provides focuses on  facial anatomy, considerations for safe injection, appropriate patient selection, and aseptic technique, ” said Shawna Chrisman , NP. “I work closely with visual specialists across the country to help them use the JUVÉDERM ® Collection associated with Fillers in order to achieve their own patients’ aesthetic goals and is truly honored to be a part of this brand’s rich history and bright future. inch

The JUVÉDERM ® Variety of Fillers currently offers five specially formulated, modified hyaluronic acid (HA) injectables to address patients’ varying face treatment needs: JUVÉDERM ® VOLUMA ® XC, JUVÉDERM ® VOLBELLA ® XC, JUVÉDERM ® VOLLURE ® XC, JUVÉDERM ® Ultra Plus XC, JUVÉDERM ® Ultra XC. The latest product approved by the FDA, JUVÉDERM ® VOLUX™ XC pertaining to improvement associated with jawline definition, will be available nationwide in early 2023. 4-10 Patients who are interested in HA fillers should schedule a consultation with their particular aesthetic specialist to see if they’re a candidate and discuss a treatment plan customized to their desired outcome.

For more information on the JUVÉDERM ® Collection of Fillers, visit Juvederm. com and follow @JUVÉDERM upon Instagram.

About Allergan Beauty

At Allergan Aesthetics, a good AbbVie organization, we develop, manufacture, plus market the portfolio associated with leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, plus more. Our own goal is to consistently provide our customers with advancement, education, exceptional service, and a commitment to excellence, all with a personal touch. To find out more, check out www.AllerganAesthetics.com .

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive in order to have a remarkable impact on people’s lives across several key therapeutic locations: immunology, oncology, neuroscience, eye care, virology, women’s wellness and gastroenterology, in addition to products and services across its Allergan Visuals portfolio. To learn more about AbbVie, please go to us at www.abbvie.com . Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

JUVÉDERM ®   Injectable Gel Fillers Important Information

APPROVED USES

JUVÉDERM ®   VOLUX™ XC injectable gel is for deep injection to improve moderate to severe loss of jawline definition in adults over the age associated with 21.

JUVÉDERM ® VOLUMA ® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to enhance the chin profile within adults over 21.

JUVÉDERM ® VOLLURE ® XC, JUVÉDERM ® Super Plus XC, and JUVÉDERM ® Ultra XC injectable gels are meant for injection into the facial tissue for the particular correction of moderate in order to severe face wrinkles and folds, such as nasolabial folds. JUVÉDERM ® VOLLURE ® XC injectable gel is designed for adults more than 21.

JUVÉDERM ® Ultra XC injectable gel is also just for injection into the lip area and perioral area for lip augmentation in adults over 21.

JUVÉDERM ® VOLBELLA ® XC injectable gel will be for shot into the lips with regard to lip enhancement and correction of perioral lines, plus for injection  into the particular undereye hollows to improve the appearance associated with undereye hollows in grown ups over the age of twenty one.

IMPORTANT SAFETY INFORMATION

Are there any reasons why I should not receive any JUVÉDERM ®   formulation?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), in case you are allergic to lidocaine or the Gram-positive bacterial proteins used in these items, or even if you have had previous allergic reactions in order to hyaluronic acidity fillers.

What warnings should the doctor advise me about?

  • One of the risks with using dermal fillers is the particular unintentional injection into a blood vessel. The chances associated with this happening are very small, but if it does happen, the complications can become serious and may end up being permanent. These complications, which have been reported regarding facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. Most associated with these events are irreversible.
  • If a person have changes in your vision, signs of the stroke (including sudden difficulty speaking, numbness or weakness in your own face, arms or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the pores and skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.
  • The use of dermal fillers where epidermis sores, pimples, rashes, hives, cysts, or even infections are present should be postponed, because this may delay healing or make skin problems worse.
  • The effectiveness of removal associated with any skin filler has not already been studied.

What precautions ought to my doctor advise me about?

  • JUVÉDERM ® VOLBELLA ® XC should only be injected into undereye hollows simply by doctors who have completed the necessary training for this particular treatment area. To find a doctor, visit Juvederm. com/find-a-specialist . Doctors that complete the training will become listed with a symbol
  • The particular safety of these products for make use of during pregnancy or while breastfeeding has not been studied
  • The security of JUVÉDERM ® VOLUMA ® XC has not been analyzed in individuals under 35 years or even over 65 years intended for cheek augmentation, or under 22 many years and over 80 yrs for face augmentation. The safety associated with JUVÉDERM ® VOLUX™ XC, JUVÉDERM ® VOLLURE ® XC and JUVÉDERM ® VOLBELLA ® XC is not researched in sufferers under 22 years, plus the protection of JUVÉDERM ® Ultra In addition XC and JUVÉDERM ® Extremely XC has not been studied within patients below 18 years
  • The basic safety and effectiveness of treatment with JUVÉDERM ® products in anatomical regions outside of their authorized uses possess not been established within clinical studies
  • If you have a brief history of excessive scarring (thick, hard scars) or pigmentation disorders, therapy in these patients offers not already been studied plus may result in additional scars or modifications in skin discoloration
  • If you are planning other procedures including laser treatments or a chemical peel, there is usually a possible risk associated with inflammation at the treatment site if these types of procedures are usually performed carefully before or after JUVÉDERM ® injectable gel treatment
  • Tell your doctor if you are on therapy used to reduce your body’s natural defense system (such as steroids, chemotherapy, and medicines to treat autoimmune diseases, HIV, plus AIDs), as these may increase your risk of infection; and medications that can prolong bleeding (such since aspirin, ibuprofen, or other blood thinners), as these may result in increased bruising or even bleeding in the injection web site
  • Avoid applying makeup to get 12 hours after treatment and minimize strenuous exercise, exposure in order to extensive sun or heat, and alcoholic beverages within the first 24 hours following therapy, as these types of may cause temporary redness, swelling, and/or itching on the shot site
  • JUVÉDERM ® VOLUMA ® XC was not examined in patients with significant loose skin from the chin, neck, or jaw
  • The particular effect associated with JUVÉDERM ® VOLUMA ® XC injection into the chin upon facial hair growth has not been studied
  • Patients who experience pores and skin injury near the web site of JUVÉDERM ® VOLUMA ® XC injection may be at a higher risk for adverse events
  • Inform your doctor in case you have already been injected along with dermal injectables in the same area as the one(s) you are about to end up being treated pertaining to. This information helps your doctor decide when plus whether a person should get treatment

What are possible side effects of therapy?
The most commonly reported side effects with JUVÉDERM ® injectable gels were redness, inflammation, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itchiness. For JUVÉDERM ® VOLBELLA ® XC, dryness was also reported.  

These side effects are consistent with some other facial shot procedures and most will resolve within 30 days. Your doctor might choose to treat part effects persisting longer along with antibiotics, steroid drugs, or hyaluronidase (an enzyme that breaks down hyaluronic acid).

As with all epidermis injection methods, there is a risk of infection.

To report a side effect with any product within the JUVÉDERM ®   Selection, please call the Allergan ®   Product Support Department in 1‑877‑345‑5372. Please also visit Juvederm. com or even talk in order to your physician for more information.

Products in the JUVÉDERM ® Collection are obtainable only by a licensed physician or properly licensed practitioner.

  References

  1. Allergan Data on File REF-96593.
  2. Allergan Data on File, Filler Situational Analysis, 2020.
  3. Allergan. Unpublished Information. INT/0008/2016(2). JUVÉDERM ® is accessible in more than 110 areas worldwide. Feb 2019 .
  4. JUVÉDERM ® Ultra XC Patient Label 2020.
  5. JUVÉDERM ® Super Plus XC Patient Label 2020.
  6. JUVÉDERM ® VOLLURE ® XC Patient Brand 2020.
  7. JUVÉDERM ® VOLUMA ® XC Patient Tag 2020.
  8. JUVÉDERM ® VOLBELLA ® XC Patient Content label 2020.
  9. JUVÉDERM ® VOLUMA ® XC Patient Label 2020.
  10. JUVÉDERM ® VOLUX XC Patient Brand 2022.
  11. Allergan Data upon File JUVÉDERM ® Clinical Studies, 2022.

SOURCE AbbVie

Leave a Reply

Your email address will not be published.